Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liechtenstein

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
BMC Cancer|October 18, 2005
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapyL Lim, P Gibbs, D Yip, et al.
Internal Medicine Journal|April 20, 2005
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignanciesL Lim, P Gibbs, D Yip, et al.
Magyar Sebeszet|February 26, 2014
[Gastrointestinal locations of primary melanoma]Arpád Rózsa, Erzsébet Mellár, Sándor Poczik, et al.
Oncotarget|October 23, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityKevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, et al.
Voprosy Virusologii|March 14, 2020
[Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.]N B Senyuta, K V Smirnova, V N Kondratova, et al.
Oncoimmunology|May 9, 2015
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using <i>ex vivo</i> myeloid-derived suppressor cells as a readout of therapeutic efficacyTherese Liechtenstein, Noemi Perez-Janices, Idoia Blanco-Luquin, et al.
Oncoimmunology|November 19, 2013
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?David Escors, Therese Liechtenstein, Noemi Perez-Janices, et al.
Oncotarget|August 25, 2014
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in miceTherese Liechtenstein, Noemi Perez-Janices, Maria Gato, et al.
Oncotarget|August 31, 2015
A core of kinase-regulated interactomes defines the neoplastic MDSC lineageMaria Gato-Cañas, Xabier Martinez de Morentin, Idoia Blanco-Luquin, et al.
Virus Research|June 4, 2013
Immune modulation by genetic modification of dendritic cells with lentiviral vectorsTherese Liechtenstein, Noemi Perez-Janices, Christopher Bricogne, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
BMC Cancer|October 18, 2005
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapyL Lim, P Gibbs, D Yip, et al.
Internal Medicine Journal|April 20, 2005
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignanciesL Lim, P Gibbs, D Yip, et al.
Magyar Sebeszet|February 26, 2014
[Gastrointestinal locations of primary melanoma]Arpád Rózsa, Erzsébet Mellár, Sándor Poczik, et al.
Oncotarget|October 23, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityKevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, et al.
Voprosy Virusologii|March 14, 2020
[Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.]N B Senyuta, K V Smirnova, V N Kondratova, et al.
Oncoimmunology|May 9, 2015
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using <i>ex vivo</i> myeloid-derived suppressor cells as a readout of therapeutic efficacyTherese Liechtenstein, Noemi Perez-Janices, Idoia Blanco-Luquin, et al.
Oncoimmunology|November 19, 2013
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?David Escors, Therese Liechtenstein, Noemi Perez-Janices, et al.
Oncotarget|August 25, 2014
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in miceTherese Liechtenstein, Noemi Perez-Janices, Maria Gato, et al.
Oncotarget|August 31, 2015
A core of kinase-regulated interactomes defines the neoplastic MDSC lineageMaria Gato-Cañas, Xabier Martinez de Morentin, Idoia Blanco-Luquin, et al.
Virus Research|June 4, 2013
Immune modulation by genetic modification of dendritic cells with lentiviral vectorsTherese Liechtenstein, Noemi Perez-Janices, Christopher Bricogne, et al.
Pageof 6